ArticleCancer research and treatmentPublished
Synergistic Antitumor Activity of Combination Therapy with a MET TKI Vabametkib and a Third-Generation EGFR TKI Lazertinib in MET-Amplified EGFR-Mutant NSCLC
Regional connection
Verified An author affiliation on the Europe PMC record names University of Pennsylvania. Affiliation source
- Institution
- University of Pennsylvania
- County
- Philadelphia County
Publication record
- Type
- Article
- Venue
- Cancer research and treatment
- Published
- Topic
- Disease research
- Subject terms
- EGFR; c-Met; Non-small cell lung cancer (NSCLC); Tyrosine Kinase Inhibitors
- PubMed ID
- 41927036
- Added to directory
- Source checked